Director, Chief Executive Officer · Seaport Therapeutics, Inc. · Common Stock
Side
G
Value
—
Shares
100.0K
Price
—
Executed
Nov 10, 2026
Disclosed
Nov 13, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Nov 10 executedNov 13, 2026 disclosed
SPTX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
No reported dollar value · 10.1% of prior position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · SPTX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Zohar Daphne filed this Form 4 reporting a gift of SPTX on Nov 10, 2026. It became public on Nov 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Zohar Daphnecik:0001727388
Issuer
Seaport Therapeutics, Inc.cik:0002042347
Revision history · 0
No field has changed since this record was first ingested.
